- Global health leader aims to drive forward sustainable healthcare practices and meaningful collaborations at the 50th edition of the global exhibition
- Prevention must be at the core of every healthcare strategy and collaboration is key to achieving this vision – M42’s Managing Director and Group Chief Executive Officer
- Cleveland Clinic in the U.S., Cleveland Clinic London and Cleveland Clinic Abu Dhabi experts to advance important Continuing Medical Education (CME) conferences that will share insights on topics such as robotic surgery, artificial intelligence, genomics and advances in cancer prevention, screening and treatment

Abu Dhabi, UAE, 21 January 2025: M42, a global health leader powered by artificial intelligence (AI) and technology, is set to lead conversations and debates on the critical areas for local and international collaboration to support global progress in healthcare at Arab Health 2025. As the Global Health Partner at the event, M42’s Managing Director and Group Chief Executive Officer, Hasan Jasem Al Nowais, said thatM42’s global health leadership sees it being at the forefront of initiatives that revolutionize healthcare and help create a healthier, more equitable world. In a world where nations are facing rising healthcare costs, mounting pressures on health systems, and rising incidences of disease, he emphasized the urgent need to shift from reactive to preventive care models and come together to plug the global healthcare gaps.
Continue reading M42 to lead strategic discussions on genomics, artificial intelligence, preventive healthcare and precision medicine at Arab Health 2025
